Cinnamoyl-N-Acylhydrazone-Donepezil Hybrids: Synthesis and Evaluation of Novel Multifunctional Ligands Against Neurodegenerative Diseases

• Published in: Neurochemical research Vol. 45; no. 12; pp. 3003 - 3020
• Main Authors: Ortiz, Cindy Juliet Cristancho, Damasio, Caio Miranda, Pruccoli, Letizia, Nadur, Nathália Fonseca, de Azevedo, Luciana Luiza, Guedes, Isabella Alvim, Dardenne, Laurent Emmanuel, Kümmerle, Arthur Eugen, Tarozzi, Andrea, Viegas, Claudio
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.12.2020; Springer Nature B.V
• Subjects: Anti-inflammatory agents; Antioxidants; Biochemistry; Biological properties; Biomedical and Life Sciences; Biomedicine; Cell Biology; Cell viability; Curcumin; Donepezil; Hybridization; Hybrids; Inflammation; Lead compounds; Ligands; Molecular docking; Movement disorders; Natural products; Neurochemistry; Neurodegenerative diseases; Neurology; Neuroprotection; Neurosciences; Neurotoxicity; Original Paper; Oxidative stress; Parkinson's disease; Piperidine; Scavenging; Multifunctional ligands; Cinnamoyl; Molecular hybridization; acylhydrazone-donepezil hybrids MTDLs; Neurodegenerative diseases
• ISSN: 0364-3190; 1573-6903
• DOI: 10.1007/s11064-020-03148-2

A new series of ten multifunctional Cinnamoyl- N -acylhydrazone-donepezil hybrids was synthesized and evaluated as multifunctional ligands against neurodegenerative diseases. The molecular hybridization approach was based on the combination of 1-benzyl-4-piperidine fragment from the anti-Alzheimer AChE inhibitor donepezil ( 1 ) and the cinnamoyl subunit from curcumin ( 2 ), a natural product with remarkable antioxidant, neuroprotective and anti-inflammatory properties, using a N -acylhydrazone fragment as a spacer subunit. Compounds 4a and 4d showed moderate inhibitory activity towards AChE with IC 50 values of 13.04 and 9.1 µM, respectively. In addition, compound 4a and 4d showed a similar predicted binding mode to that observed for donepezil in the molecular docking studies. On the other hand, compounds 4a and 4c exhibited significant radical scavenging activity, showing the best effects on the DPPH test and also exhibited a significant protective neuronal cell viability exposed to t-BuOOH and against 6-OHDA insult to prevent the oxidative stress in Parkinson’s disease. Similarly, compound 4c was capable to prevent the ROS formation, with indirect antioxidant activity increasing intracellular GSH levels and the ability to counteract the neurotoxicity induced by both OAβ1-42 and 3-NP. In addition, ADMET in silico prediction indicated that both compounds 4a and 4c did not show relevant toxic effects. Due to their above-mentioned biological properties, compounds 4a and 4c could be explored as lead compounds in search of more effective and low toxic small molecules with multiple neuroprotective effects for neurodegenerative diseases. Graphic Abstract